EC Healthcare announced sales guidance for the quarter of April to June 2022. For the period, the company expected overall Sales Volume of no less than HKD 860 million for the Quarter, representing an increase of no less than 17% as compared with the same period last year and an increase of no less than 80% as compared with the same period in 2020; a decrease in Sales Volume in those clinics and service centers located in Mainland China of no more than 6% for the Quarter as compared with the same period last year and an increase of no less than 29% as compared with the same period in 2020; and an increase in Sales Volume of medical services offered by the Group of no less than 29% for the Quarter as compared with the same period last year and an increase of no less than 158% as compared with the same period in 2020.